|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chlordane | CAS 57-74-9 | ||
| C10H6Cl8 | RTECS PB9800000 | ||
|
Synonyms & Trade Names Chlordan; Chlordano; 1,2,4,5,6,7,8,8-Octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane |
DOT ID & Guide 2762 131 |
||
|
Exposure Limits |
NIOSH REL: Ca TWA 0.5 mg/m3 [skin] See Appendix A | ||
| OSHA PEL: TWA 0.5 mg/m3 [skin] | |||
| IDLH Ca [100 mg/m3] | Conversion | ||
|
Physical Description Amber-colored, viscous liquid with a pungent, chlorine-like odor. [insecticide] |
|||
|
MW: 409.8 |
BP: Decomposes |
FRZ: 217-228°F |
Sol: 0.0001% |
|
VP: 0.00001 mmHg |
IP: ? |
|
Sp.Gr(77°F): 1.6 |
|
Fl.P: NA |
UEL: NA |
LEL: NA |
|
| Noncombustible Liquid, but may be utilized in flammable solutions. | |||
|
Incompatibilities & Reactivities Strong oxidizers, alkaline reagents |
|||
|
Measurement Methods NIOSH 5510; OSHA 67 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Blurred vision; confusion; ataxia, delirium; cough; abdominal pain, nausea, vomiting, diarrhea; irritability, tremor, convulsions; anuria; in animals: lung, liver, kidney damage; [potential occupational carcinogen] | |
|
Target Organs
central nervous system, eyes, lungs, liver, kidneys Cancer Site [in animals: liver cancer] |
|
| See also: INTRODUCTION |